Advanced Prostate Cancer Consensus Conference (APCCC 2021)
Novartis 177Lu-PSMA-617 significantly improves overall survival and radiographic progression-free survival for men with metastatic castration-resistant prostate cancer in Phase III VISION study
Novartis reports clinically relevant improvement in median overall survival data in final analysis of pivotal NETTER-1 study with targeted radioligand therapy Lutathera
WorldMEN (17th International Workshop on Multiple Endocrine Neoplasia and other Rare Endocrine Tumors)
Journées Francophones d’Hépato-gastroentérologie et d’Oncologie Digestive (JFHOD)
114ème Congrès Français d’Urologie
23rd European Congress of Endocrinology (ECE)
American Society of Clinical Oncology (ASCO) Annual Meeting
Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
ESMO (European Society for Medical Oncology) Congress